Envoy Medical, Inc. (COCH) Financial Statements
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
In fiscal 2025, Envoy Medical reported revenue of $241,000, up 7.1% from $225,000 the year before. Net income was -$23.8M (a -9857.3% net margin), or -$1.23 per diluted share. Gross margin was -262.7% and operating margin was -9240.7%. Operating activities generated -$18.2M of cash, leaving -$18.4M of free cash flow. At fiscal year end, Envoy Medical held $8.6M in total assets against $20.3M in total liabilities.
Open the full interactive Envoy Medical financials → Quarterly statements, key ratios, valuation history and price charts.
Envoy Medical Key Stats
| Share Price | $0.66 |
|---|---|
| Market Cap | $68.6M |
| Dividend Yield | 2.65% |
| Revenue YoY Growth | +7.1% |
| 52-Week Range | $0.39 – $0.92 |
| Shares Outstanding | 104.0 million (basic, 2026 Q2) |
Envoy Medical Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $316,000 | $225,000 | $241,000 |
| Cost of Goods Sold | $0 | $0 | $789,000 | $742,000 | $874,000 |
| Gross Profit | $0 | $0 | -$473,000 | -$517,000 | -$633,000 |
| Operating Income | -$5.2M | -$4.9M | -$18.4M | -$19.3M | -$22.3M |
| Pre-Tax Income | -$251,633 | $20.7M | -$29.9M | -$20.8M | -$23.8M |
| Income Tax | — | $1.5M | — | — | — |
| Net Income | -$251,633 | $19.2M | -$29.9M | -$20.8M | -$23.8M |
| Diluted EPS | -$0.01 | $0.36 | -$2.38 | -$1.49 | -$1.23 |
Envoy Medical Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $42,000 | $75,000 | $39,000 | $51,000 |
| Net Income | -$6.5M | -$6.6M | -$4.4M | -$6.0M |
| Diluted EPS | -$0.35 | -$0.28 | -$0.08 | -$0.07 |
Envoy Medical Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $149,845 | $107,773 | $4.2M | — | — |
| Current Assets | $863,167 | $220,422 | $6.8M | $9.4M | $6.3M |
| Total Assets | $426.9M | $430.6M | $7.6M | $11.5M | $8.6M |
| Current Liabilities | $2.7M | $7.3M | $6.6M | $7.5M | $11.6M |
| Total Long-Term Debt | — | — | $2.5M | — | — |
| Total Liabilities | $38.6M | $18.8M | $9.4M | $30.4M | $20.3M |
| Shareholders' Equity | -$36.7M | -$17.9M | -$1.8M | -$18.8M | -$12.2M |
Envoy Medical Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$3.2M | -$2.7M | -$17.7M | -$17.9M | -$18.2M |
| Cash From Investing | -$425.0M | $1.1M | -$153,000 | -$980,000 | -$179,000 |
| Cash From Financing | $428.4M | $1.5M | $21.8M | $20.2M | $16.6M |
| Free Cash Flow | — | — | -$17.8M | -$18.9M | -$18.4M |
| Dividends Paid | — | — | — | $2.4M | $1.8M |
Figures from Envoy Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Envoy Medical financials page for every line item.
Envoy Medical Company Profile
| Ticker | COCH |
|---|---|
| Exchange | Nasdaq |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Headquarters | White Bear Lake, Minnesota |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001840877 |
Frequently Asked Questions
What was Envoy Medical's revenue in fiscal 2025?
Envoy Medical (COCH) reported revenue of $241,000 for fiscal 2025.
What is Envoy Medical's annual revenue history?
Envoy Medical's annual revenue by fiscal year: 2021: $0; 2022: $0; 2023: $316,000; 2024: $225,000; 2025: $241,000.
What was Envoy Medical's net income in fiscal 2025?
Envoy Medical reported net income of -$23.8M for fiscal 2025.
What was Envoy Medical's earnings per share (EPS) in fiscal 2025?
Envoy Medical's diluted EPS was -$1.23 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Envoy Medical generate in fiscal 2025?
Envoy Medical generated -$18.4M of free cash flow in fiscal 2025.
What was Envoy Medical's revenue last quarter?
In its most recent reported quarter (2026 Q2), Envoy Medical reported revenue of $51,000.
How many shares of Envoy Medical are outstanding?
Envoy Medical reported a weighted average of 104.0 million basic shares outstanding in 2026 Q2.
What is Envoy Medical's market cap?
Based on its latest closing price, Envoy Medical (COCH) has a market capitalization of about $68.6M.
When does Envoy Medical's fiscal year end?
Envoy Medical's fiscal year end, as registered with the SEC, is December 31.
Where is Envoy Medical headquartered?
Envoy Medical lists its business address in White Bear Lake, Minnesota in its SEC filings.